Karyopharm Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
EXOME ASSET MANAGEMENT LLC | 05/15/2025 | 2.00 M | $1.52 M | 100.00% | 1.64% |
VANGUARD GROUP INC | 05/09/2025 | 510.29 K | $1.91 M | 100.00% | 0.42% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 421.32 K | $1.58 M | 100.00% | 0.35% |
EVERSEPT PARTNERS, LP | 05/15/2025 | 257.15 K | $961.76 K | 100.00% | 0.21% |
BLACKROCK, INC. | 05/02/2025 | 242.74 K | $907.86 K | 100.00% | 0.20% |
CITADEL ADVISORS LLC | 05/15/2025 | 206.91 K | $773.84 K | 100.00% | 0.17% |
JPMORGAN CHASE & CO | 05/12/2025 | 170.79 K | $638.76 K | 100.00% | 0.14% |
05/15/2025 | 155.62 K | $582.03 K | 100.00% | 0.13% | |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 139.65 K | $523.00 K | 100.00% | 0.11% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 132.91 K | $497.08 K | 100.00% | 0.11% |
MARSHALL WACE, LLP | 05/15/2025 | 128.45 K | $480.41 K | 100.00% | 0.11% |
C WORLDWIDE GROUP HOLDING A/S | 05/05/2025 | 100.00 K | $374.00 K | 100.00% | 0.08% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 99.64 K | $372.74 K | 100.00% | 0.08% |
UBS GROUP AG | 05/13/2025 | 93.61 K | $350.11 K | 100.00% | 0.08% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 85.41 K | $319.43 K | 100.00% | 0.07% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 63.80 K | $238.61 K | 100.00% | 0.05% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 61.21 K | $228.94 K | 100.00% | 0.05% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 55.37 K | $207.07 K | 100.00% | 0.05% |
SILVERBACK ASSET MANAGEMENT LLC | 05/15/2025 | 50.00 K | $187.00 K | 100.00% | 0.04% |
STATE STREET CORP | 05/15/2025 | 29.50 K | $110.31 K | 100.00% | 0.02% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 28.96 K | $108.31 K | 100.00% | 0.02% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 27.26 K | $101.94 K | 100.00% | 0.02% |
SHAY CAPITAL LLC | 05/15/2025 | 25.42 K | $95.06 K | 100.00% | 0.02% |
UBS OCONNOR LLC | 05/15/2025 | 23.64 K | $88.41 K | 100.00% | 0.02% |
NORTHERN TRUST CORP | 05/13/2025 | 18.91 K | $70.72 K | 100.00% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 11.55 K | $43.19 K | 100.00% | 0.01% |
JANE STREET GROUP, LLC | 05/19/2025 | 11.42 K | $42.71 K | 100.00% | 0.01% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 11.09 K | $41.46 K | 100.00% | 0.01% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 11.00 K | $41.14 K | 100.00% | 0.01% |
CITADEL ADVISORS LLC | 05/15/2025 | 10.80 K | $40.39 K | 100.00% | 0.01% |
MORGAN STANLEY | 05/15/2025 | 10.42 K | $38.98 K | 100.00% | 0.01% |
CITIGROUP INC | 05/12/2025 | 7.04 K | $26.35 K | 100.00% | 0.01% |
BARCLAYS PLC | 05/15/2025 | 5.33 K | $19.00 K | 100.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 3.58 K | $13.38 K | 100.00% | 0.00% |
TD WATERHOUSE CANADA INC. | 05/09/2025 | 3.20 K | $11.28 K | 100.00% | 0.00% |
ROYAL BANK OF CANADA | 05/15/2025 | 1.46 K | $5.00 K | 100.00% | 0.00% |
FMR LLC | 05/12/2025 | 527 | $1.97 K | 100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 346 | $1.29 K | 100.00% | 0.00% |
COLDSTREAM CAPITAL MANAGEMENT INC | 05/13/2025 | 331 | $1.24 K | 100.00% | 0.00% |
QUENT CAPITAL, LLC | 04/04/2025 | 231 | $864 | 100.00% | 0.00% |
05/06/2025 | 133 | $497 | 100.00% | 0.00% | |
05/07/2025 | 100 | $374 | 100.00% | 0.00% | |
HARBOUR INVESTMENTS, INC. | 05/08/2025 | 85 | $318 | 100.00% | 0.00% |
05/02/2025 | 74 | $277 | 100.00% | 0.00% | |
ACTIVEST WEALTH MANAGEMENT | 05/15/2025 | 66 | $247 | 100.00% | 0.00% |
ALLWORTH FINANCIAL LP | 04/30/2025 | 32 | $192 | 100.00% | 0.00% |
BRUCE G. ALLEN INVESTMENTS, LLC | 04/14/2025 | 22 | $82 | 100.00% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 05/14/2025 | 3 | $12 | 100.00% | 0.00% |
WEST BRANCH CAPITAL LLC | 04/16/2025 | 3 | $12 | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
Karyopharm Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 118 institutional investors and hedge funds held shares of Karyopharm Therapeutics Inc.. The most heavily invested institutionals were:
Quent Capital, LLC: 0
Exome Asset Management LLC: 2 M
VANGUARD GROUP INC: 510,294
ADAGE CAPITAL PARTNERS GP, L.L.C.: 421,322
Eversept Partners, LP: 257,154
BlackRock, Inc.: 242,742
4.25% of Karyopharm Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.77 M shares in the last 24 months. This purchase volume represents approximately $76.66 M in transactions.